SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 191.65 |
Enterprise Value ($M) | 154.67 |
Book Value ($M) | 266.97 |
Book Value / Share | 4.44 |
Price / Book | 0.72 |
NCAV ($M) | 203.46 |
NCAV / Share | 3.39 |
Price / NCAV | 0.94 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.18 |
Return on Assets (ROA) | -0.28 |
Return on Equity (ROE) | -0.29 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 19.01 |
Current Ratio | 19.01 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 246.62 |
Assets | 310.12 |
Liabilities | 43.15 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -61.14 |
Net Income | -52.37 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -43.06 |
Cash from Investing | -171.67 |
Cash from Financing | 151.75 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Deep Track Capital, LP | 0.00 | -100.00 | |
13G | Franklin Resources Inc | 5.80 | ||
13G/A | Murray James B Jr | 4.60 | 3.87 | |
13D/A | Ra Capital Management, L.p. | 25.90 | 53.27 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
18,343 | 134,449 | 13.64 | |
43,505 | 43,153 | 100.82 | |
23,028 | 44,364 | 51.91 | |
32,391 | 70,894 | 45.69 | |
(click for more detail) |
Similar Companies | |
---|---|
ABCL – AbCellera Biologics Inc. | ABUS – Arbutus Biopharma Corporation |
ACAD – ACADIA Pharmaceuticals Inc. |
Financial data and stock pages provided by
Fintel.io